Human interleukin-2 cDNA sequence
US4761375A · kind A · utility
28Cited by
2References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 7, 1986 |
| Grant date | Aug 2, 1988 |
| Priority date | — |
| Expiry date | Apr 7, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The mRNA of a distinct human Interleukin-2 concentrated from a plasma source lead to the production and cloning of its cDNA and the elucidation of its sequence and that of the mature protein. Transfer vectors for production of such Interleukin-2 are disclosed along with useful intermediate expression products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.